Scholtz & Company’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
CAM
CCA
GKIM
SCM
Scholtz & Company's VCEL Position: Q2 2026 in Review
Scholtz & Company opened a new position in Vericel Corp (VCEL) in Q2 2026: 51,409 shares worth $2.29M. The stake represents 1.14% of the portfolio and ranks #29 among its holdings. This is a return to the name: Scholtz & Company previously reported a position in VCEL as recently as Q2 2025.
Scholtz & Company first reported a position in VCEL in Q2 2024 and has held it in 6 quarters since. The position peaked at $2.62M in Q4 2024. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.
- Scholtz & Company held 51,409 shares of Vericel Corp worth $2.29M as of Q2 2026.
- Vericel Corp was a new Scholtz & Company position in Q2 2026.
- Vericel Corp made up 1.14% of Scholtz & Company's portfolio in Q2 2026, its #29 holding.
- Scholtz & Company first reported a position in Vericel Corp in Q2 2024 and has held it in 6 quarters since.
- Scholtz & Company's Vericel Corp position peaked at $2.62M in Q4 2024.
- 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.
Based on Scholtz & Company's 13F filing for Q2 2026, filed 11 Aug 2026.